<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Development of chemoresistance, poor prognosis, and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> often renders the current treatments for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) ineffective </plain></SENT>
<SENT sid="1" pm="."><plain>Whether <z:chebi fb="0" ids="9908">ursolic acid</z:chebi>, a component of numerous medicinal plants, either alone or in combination with <z:chebi fb="0" ids="31348">capecitabine</z:chebi>, can inhibit the growth and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> was investigated </plain></SENT>
<SENT sid="2" pm="."><plain>Experimental design: The effect of <z:chebi fb="0" ids="9908">ursolic acid</z:chebi> on proliferation of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cell lines was examined by <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dye uptake assay, <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by esterase staining, NF-κB activation by DNA-binding assay, and protein expression by Western blot </plain></SENT>
<SENT sid="3" pm="."><plain>The effect of <z:chebi fb="0" ids="9908">ursolic acid</z:chebi> on the growth and chemosensitization was also examined in orthotopically implanted <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in <z:mp ids='MP_0003815'>nude</z:mp> mice </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: We found that <z:chebi fb="0" ids="9908">ursolic acid</z:chebi> inhibited the proliferation of different <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cell lines </plain></SENT>
<SENT sid="5" pm="."><plain>This is correlated with inhibition of constitutive NF-κB activation and downregulation of cell survival (Bcl-xL, Bcl-2, cFLIP, and survivin), proliferative (cyclin D1), and metastatic (MMP-9, VEGF, and ICAM-1) proteins </plain></SENT>
<SENT sid="6" pm="."><plain>When examined in an orthotopic <z:mp ids='MP_0003815'>nude</z:mp> mouse model, <z:chebi fb="0" ids="9908">ursolic acid</z:chebi> significantly inhibited <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> volume, <z:hpo ids='HP_0001541'>ascites</z:hpo> formation, and distant organ <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, and this effect was enhanced with <z:chebi fb="0" ids="31348">capecitabine</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>Immunohistochemistry of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue indicated that <z:chebi fb="0" ids="9908">ursolic acid</z:chebi> downregulated biomarkers of proliferation (Ki-67) and microvessel density (CD31) </plain></SENT>
<SENT sid="8" pm="."><plain>This effect was accompanied by suppression of NF-κB, STAT3, and β-catenin </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, <z:chebi fb="0" ids="9908">ursolic acid</z:chebi> suppressed EGF receptor (EGFR) and induced p53 and p21 expression </plain></SENT>
<SENT sid="10" pm="."><plain>We also observed bioavailability of <z:chebi fb="0" ids="9908">ursolic acid</z:chebi> in the serum and tissue of animals </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: Overall, our results show that <z:chebi fb="0" ids="9908">ursolic acid</z:chebi> can inhibit the growth and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and further enhance the therapeutic effects of <z:chebi fb="0" ids="31348">capecitabine</z:chebi> through the suppression of multiple biomarkers linked to <z:mp ids='MP_0001845'>inflammation</z:mp>, proliferation, invasion, <z:mpath ids='MPATH_177'>angiogenesis</z:mpath>, and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
</text></document>